vitrase
Generic: hyaluronidase, ovine
Labeler: bausch & lomb incorporatedDrug Facts
Product Profile
Brand Name
vitrase
Generic Name
hyaluronidase, ovine
Labeler
bausch & lomb incorporated
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
hyaluronidase (ovine) 200 [USP'U]/mL
Manufacturer
Identifiers & Regulatory
Product NDC
24208-002
Product ID
24208-002_199929ae-773d-c474-e063-6394a90ab8bc
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA021640
Listing Expiration
2026-12-31
Marketing Start
2005-02-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
24208002
Hyphenated Format
24208-002
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
vitrase (source: ndc)
Generic Name
hyaluronidase, ovine (source: ndc)
Application Number
BLA021640 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 [USP'U]/mL
Packaging
- 16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied VITRASE ® (hyaluronidase injection) is supplied as 200 USP units/mL of sterile, non-preserved, clear and colorless solution in a single-dose, glass vial with a rubber stopper and aluminum seal. Discard unused portion. NDC 24208-002-02: 200 USP units/mL in a single-dose vial (NDC 24208-002-03) available in a carton containing 2 single-dose vials. 16.2 Storage and Handling Protect from light. Store unopened vial in refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze.
- PACKAGE/LABEL PRINCIPAL DISPLAY PANEL – Vitrase Carton Label NDC 24208-002-02 Hyaluronidase Injection Vitrase ® 200 USP Units/mL Derived from ovine testicle Sterile NOT FOR IV USE Rx only BAUSCH+LOMB Two-1 ml Single-Dose Vials. Discard unused portion. 9427704 carton
Packages (0)
No package records.
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "199929ae-773d-c474-e063-6394a90ab8bc", "openfda": {"unii": ["64R4OHP8T0"], "rxcui": ["486166", "582692"], "spl_set_id": ["21fbd12e-4a12-4ad1-ad01-964cd5ec9996"], "manufacturer_name": ["Bausch & Lomb Incorporated"], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "VITRASE", "product_id": "24208-002_199929ae-773d-c474-e063-6394a90ab8bc", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Endoglycosidase [EPC]", "Glycoside Hydrolases [CS]"], "product_ndc": "24208-002", "generic_name": "hyaluronidase, ovine", "labeler_name": "Bausch & Lomb Incorporated", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VITRASE", "active_ingredients": [{"name": "HYALURONIDASE (OVINE)", "strength": "200 [USP'U]/mL"}], "application_number": "BLA021640", "marketing_category": "BLA", "marketing_start_date": "20050201", "listing_expiration_date": "20261231"}